|
|
- 2019
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical GuidelinesDOI: https://doi.org/10.1016/j.molmed.2018.12.006 Abstract: MSC products have largely diversified during the past decade, making extrapolation about safety and efficacy from first-generation products inappropriate
|
